
Entero Healthcare Declares Unaudited Q1 FY27 Results
Entero Healthcare Solutions Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results, along with unmodified Limited Review Reports from the statutory auditors. The company also reconstituted its Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee, effective August 25, 2026, due to the completion of a director's tenure. The trading window for securities will open 48 hours after the disclosure of these financial results.
Key Highlights
- Unaudited standalone and consolidated financial results for Q1 FY27 declared.
- Limited Review Reports with unmodified opinions were approved.
- Board committees reconstituted effective August 25, 2026.
- Trading window to open 48 hours post-disclosure.
Price Impact
More from ENTERO
Entero Healthcare Q1FY27: consolidated PAT +72% YoY to ₹52 Cr, OPM hits 5% target
Entero Healthcare Solutions Ltd: Revised Earnings Call Intimation
Entero Healthcare Solutions Incorporates Step-Down Subsidiary Qurovia Lifesciences